FINAXIONResearch
Finaxion Research · The MACD cross (12/26/9) · single stocks · Recomputed 2026-09-10

Does the MACD cross (12/26/9) work on PSKY?

The MACD cross (12/26/9) beats buy-and-hold on PSKY by +3.4 points a year over 21 years.

Total return
33.1%
Buy and hold
-34.8%
CAGR
1.4%
Sharpe
0.09
Max drawdown
-85.4%
Trades
409
Out of sample
overfit
Years
21
20062008201020122014201620182020202220242026
StrategyPSKY

Findings

  1. The MACD cross (12/26/9) beats buy-and-hold on PSKY by +3.4 points a year over 21 years.
  2. Against the S&P 500 over the same window: -9.7 points a year.
  3. Total return +33.1% versus -34.8% for buy-and-hold, with 409 trades.
  4. The result does not hold out of sample: it is overfit.
  5. Maximum drawdown -85.4%.
  6. It did not beat before 2016 and started afterwards.
  7. It ranks #160 of 235 markets for this strategy by annual excess over the S&P 500.

Findings derived from the full panel. Each carries its number and its denominator; the computations are reproducible with artifact 71812b470df2.

Exactly what was tested

Long while the MACD(12,26) line is above its signal(9); flat when below. Next-close execution.

How to read it

The verdict compares the strategy with buying and holding PSKY over the same window, with round-trip costs per asset class. “Out of sample” is walk-forward: the rule is fit on one stretch and judged on the next. A result that beats in the full sample but not out of it is overfit. Full methodology in the protocol. How we test.

Open this backtest with its trades   Trades (CSV)

Every strategy on PSKY → · Full page for The MACD cross (12/26/9) →

How to cite

Finaxion Research (2026). Does the MACD cross (12/26/9) work on PSKY?. Daily backtest 1962-01-01–2026-08-31, artifact 71812b470df2. https://finaxion.app/en/research/classic-macd/psky

Not a recommendation. Past performance does not guarantee future results.